These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8369082

  • 1. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V, Holly A, Bujía J, Schulz P.
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [Abstract] [Full Text] [Related]

  • 2. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E.
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [Abstract] [Full Text] [Related]

  • 3. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V, Bujia J, Negri B, Kastenbauer E.
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [Abstract] [Full Text] [Related]

  • 4. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
    Bujía J, Holly A, Kim C, Schilling V, Kastenbauer E.
    Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
    [Abstract] [Full Text] [Related]

  • 5. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S, Zheng X, Carlsöö B.
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [Abstract] [Full Text] [Related]

  • 6. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
    Sudhoff H, Bujía J, Holly A, Kim C, Fisseler-Eckhoff A.
    Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
    [Abstract] [Full Text] [Related]

  • 7. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
    Schulz P, Bujía J, Holly A, Shilling V, Kastenbauer E.
    Am J Otolaryngol; 1993 Mar; 14(2):82-7. PubMed ID: 8484481
    [Abstract] [Full Text] [Related]

  • 8. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
    Schilling V, Bujía J, Holly A, Schulz P.
    Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical studies of vascularization of cholesteatoma].
    Stammberger M, Holly A, Bujia J.
    Laryngorhinootologie; 1993 Apr; 72(4):170-3. PubMed ID: 7684226
    [Abstract] [Full Text] [Related]

  • 10. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
    Xu Y, Wu Z, Tao Z, Hua Q, Jin K.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
    [Abstract] [Full Text] [Related]

  • 11. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
    Holly A, Bujía J, Sanchez-Madrid F.
    Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
    [Abstract] [Full Text] [Related]

  • 12. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-alpha.
    Maas-Szabowski N, Stärker A, Fusenig NE.
    J Cell Sci; 2003 Jul 15; 116(Pt 14):2937-48. PubMed ID: 12771184
    [Abstract] [Full Text] [Related]

  • 13. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
    Sudhoff H, Borkowski G, Bujia J, Hildmann H, Fisseler-Eckhoff A.
    HNO; 1997 Aug 15; 45(8):630-5. PubMed ID: 9378670
    [Abstract] [Full Text] [Related]

  • 14. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P.
    Laryngoscope; 1993 Mar 15; 103(3):326-9. PubMed ID: 7680089
    [Abstract] [Full Text] [Related]

  • 15. [Origin of acquired middle ear cholesteatoma].
    Zechner G.
    Laryngol Rhinol Otol (Stuttg); 1985 Feb 15; 64(2):67-72. PubMed ID: 3982178
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep 15; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 17. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R, Welkoborsky HJ, Mann W.
    Laryngorhinootologie; 2001 Jan 15; 80(1):11-7. PubMed ID: 11272241
    [Abstract] [Full Text] [Related]

  • 18. [Expression of calgranulin A and B in middle ear cholesteatoma].
    Holly A, Bujía J, Lempart K, Serge M.
    Laryngorhinootologie; 1995 Jan 15; 74(1):33-5. PubMed ID: 7888019
    [Abstract] [Full Text] [Related]

  • 19. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
    Liu J, Lin G, Huang J, Jiang Z.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb 15; 37(1):30-3. PubMed ID: 12768791
    [Abstract] [Full Text] [Related]

  • 20. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ, Yuspa SH.
    Cancer Res; 1995 May 01; 55(9):1883-93. PubMed ID: 7728756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.